Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2015.63.pdf
Reference68 articles.
1. Bozzetti, F., Saccozzi, R., De Lena, M. & Salvadori, B. Inflammatory cancer of the breast: analysis of 114 cases. J. Surg. Oncol. 18, 355–361 (1981).
2. Haagensen, C. D. & Stout, A. P. Carcinoma of the breast. III. Results of treatment, 1935–1942. Ann. Surg. 134, 151–172 (1951).
3. Bonadonna, G. et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N. Engl. J. Med. 294, 405–410 (1976).
4. Fisher, B. et al. 1-phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N. Engl. J. Med. 292, 117–122 (1975).
5. Buzdar, A. U., Montague, E. D., Barker, J. L., Hortobagyi, G. N. & Blumenschein, G. R. Management of inflammatory carcinoma of breast with combined modality approach—an update. Cancer 47, 2537–2542 (1981).
Cited by 177 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The longitudinal changes in multiparametric MRI during neoadjuvant chemotherapy can predict treatment response early in patients with HER2-positive breast cancer;European Journal of Radiology;2024-09
2. Fluctuations in serum lipid levels during neoadjuvant treatment as novel predictive and prognostic biomarkers for locally advanced breast cancer: a retrospective analysis based on a prospective cohort;Lipids in Health and Disease;2024-08-22
3. Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer;Clinical Breast Cancer;2024-08
4. Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy;BMC Cancer;2024-07-02
5. Investigating the Association Between Type 2 Diabetes Mellitus and Pathological Responses Among Breast Cancer Patients Receiving Neoadjuvant Chemotherapy;Journal of Surgical Research;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3